Logo image of ESGC

EROS STX GLOBAL CORP (ESGC) Stock Fundamental Analysis

NYSE:ESGC - New York Stock Exchange, Inc. - IM00BMT7S123 - Common Stock

3.03  +0.55 (+22.18%)

After market: 2.88 -0.15 (-4.95%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ESGC. ESGC was compared to 71 industry peers in the Entertainment industry. ESGC may be in some trouble as it scores bad on both profitability and health. ESGC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ESGC was profitable.
ESGC Yearly Net Income VS EBIT VS OCF VS FCFESGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA -37.44%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESGC Yearly ROA, ROE, ROICESGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -45.47%
PM (TTM) -269.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ESGC Yearly Profit, Operating, Gross MarginsESGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ESGC has more shares outstanding
The debt/assets ratio for ESGC is higher compared to a year ago.
ESGC Yearly Shares OutstandingESGC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M
ESGC Yearly Total Debt VS Total AssetsESGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 500M 1B

2.2 Solvency

ESGC has an Altman-Z score of -2.49. This is a bad value and indicates that ESGC is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.71 indicates that ESGC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -2.49
ROIC/WACCN/A
WACCN/A
ESGC Yearly LT Debt VS Equity VS FCFESGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.52 indicates that ESGC may have some problems paying its short term obligations.
A Quick Ratio of 0.52 indicates that ESGC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
ESGC Yearly Current Assets VS Current LiabilitesESGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 100M 200M 300M

5

3. Growth

3.1 Past

ESGC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 185.97%, which is quite impressive.
ESGC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.11% yearly.
Looking at the last year, ESGC shows a very negative growth in Revenue. The Revenue has decreased by -42.43% in the last year.
ESGC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.36% yearly.
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%

3.2 Future

Based on estimates for the next years, ESGC will show a very negative growth in Earnings Per Share. The EPS will decrease by -34.09% on average per year.
The Revenue is expected to grow by 69.34% on average over the next years. This is a very strong growth
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESGC Yearly Revenue VS EstimatesESGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ESGC Yearly EPS VS EstimatesESGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

2

4. Valuation

4.1 Price/Earnings Ratio

ESGC is valuated cheaply with a Price/Earnings ratio of 1.53.
When comparing the Price/Earnings ratio of ESGC to the average of the S&P500 Index (26.68), we can say ESGC is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for ESGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 1.53
Fwd PE N/A
ESGC Price Earnings VS Forward Price EarningsESGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -133.2
ESGC Per share dataESGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ESGC's earnings are expected to decrease with -67.73% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%

0

5. Dividend

5.1 Amount

ESGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EROS STX GLOBAL CORP

NYSE:ESGC (6/3/2022, 8:17:40 PM)

After market: 2.88 -0.15 (-4.95%)

3.03

+0.55 (+22.18%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)01-14 2022-01-14/bmo
Earnings (Next)06-17 2022-06-17/bmo
Inst Owners59.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.42M
Analysts82.86
Price Target3.57 (17.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.53
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB N/A
EV/EBITDA -133.2
EPS(TTM)1.98
EY65.35%
EPS(NY)-4.14
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.21
BVpS21.24
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA -37.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -45.47%
PM (TTM) -269.45%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -2.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A